AACC Launches COVID-19 Immunity Study at 2021 Annual Scientific Meeting and Clinical Lab Expo
By LabMedica International staff writers Posted on 31 Aug 2021 |
Illustration
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) is launching the COVID-19 Immunity Study, which will examine immune responses to SARS-CoV-2 vaccination or prior infection in a diverse group of volunteers.
Despite continued efforts by the scientific community to understand all aspects of COVID-19, it is still not known how long the currently available SARS-CoV-2 vaccines can provide protection against the SARS-CoV-2 virus. In order to gain further insights into this issue, AACC’s study will also further examine the utility of serologic tests as a means to measure lasting immunity.
AACC will collect blood samples for the planned study from attendees and exhibitors at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo to be held in Atlanta on September 28-30. All study participants must be 18 years of age and efforts will be made to ensure that the research cohort is as diverse as possible. This approach to sample collection is modeled after AACC’s Universal Sample Bank program, which used samples from attendees of the 2015 AACC Annual Scientific Meeting in support of important research related to troponin. People who are unable to attend the meeting in person can also contribute to the study by submitting answers to a 10-minute COVID-19 health questionnaire. In return for donating blood, the study participants will receive the results of their individual antibody profile tests after all the collected samples have been analyzed.
Related Links:
American Association for Clinical Chemistry
Despite continued efforts by the scientific community to understand all aspects of COVID-19, it is still not known how long the currently available SARS-CoV-2 vaccines can provide protection against the SARS-CoV-2 virus. In order to gain further insights into this issue, AACC’s study will also further examine the utility of serologic tests as a means to measure lasting immunity.
AACC will collect blood samples for the planned study from attendees and exhibitors at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo to be held in Atlanta on September 28-30. All study participants must be 18 years of age and efforts will be made to ensure that the research cohort is as diverse as possible. This approach to sample collection is modeled after AACC’s Universal Sample Bank program, which used samples from attendees of the 2015 AACC Annual Scientific Meeting in support of important research related to troponin. People who are unable to attend the meeting in person can also contribute to the study by submitting answers to a 10-minute COVID-19 health questionnaire. In return for donating blood, the study participants will receive the results of their individual antibody profile tests after all the collected samples have been analyzed.
Related Links:
American Association for Clinical Chemistry
Latest AACC 2021 News
- Study Showing Differing COVID-19 Antibody Profiles Among Vaccinated and Naturally Infected Individuals Presented at AACC 2021
- Study Reveals Varying Antibody Responses and Adverse Reactions Among Recipients of Different COVID-19 Vaccines
- Novel Study on Performance of Coronavirus Tests in Children Presented at 2021 AACC Annual Scientific Meeting
- New Rapid Test That Identifies Deteriorating COVID-19 Patients with Greater Accuracy than Existing Tests Presented at AACC 2021
- New Blood Test for Occupational Stress Identifies Healthcare Professionals Burned out from COVID-19 Pandemic
- New Non-Invasive Saliva Test for Early and Accurate Detection of Prostate Cancer Presented at AACC 2021
- New Non-Invasive Blood Test for Colon Cancer Presented at 2021 AACC Annual Scientific Meeting
- Study Establishing Accurate Reference Intervals for Pregnant Patients Presented at AACC 2021
- New Test that Measures Antibodies in Girls Who Have Received HPV Vaccine Presented at AACC 2021
- Novel Insights on COVID-19 Vaccines and Virus Evolution, AI in the Clinic, and Miniaturization of Diagnostic Platforms Explored at AACC 2021
- Seegene Unveils New STARlet-AIOS All-in-One Solution for All Molecular Testing at AACC 2021
- Group K Diagnostics Demonstrates KromaHealth Kit that Enables Lab-Quality Results at Point-of-Care
- NGeneBio Showcases NGS-Based Oncology/Genetic Diseases Kits and NGenePlex nCoV qRT-PCR Kit Against COVID-19
- Visby Medical Presents New Portable PCR COVID-19 Test Kit at 2021 AACC Annual Scientific Meeting & Clinical Lab Expo
- Fluxergy Introduces First-of-Its-Kind Multi-Modal Laboratory Platform That Diagnoses COVID-19 On-Site in 60 Minutes
- Mammoth Biosciences Presents AACC 2021 Disruptive Technology Award Finalist CRISPR-Based Detection Platform